Literature DB >> 6863541

Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.

R Yarchoan, H S Schneider, B B Wray, D L Nelson.   

Abstract

Specific anti-influenza virus antibody production in vitro was studied in peripheral blood mononuclear cells from 17 patients with hypogammaglobulinemia. Cells obtained from 6 of 12 patients with common variable hypogammaglobulinemia produced anti-influenza virus antibody, predominantly of the IgM isotype, when cultured in vitro with type A influenza virus. No antibody was produced in vitro, however, by cells from either of two patients with Bruton's type X-linked hypogammaglobulinemia or by cells from any of three patients with X-linked hypogammaglobulinemia and isolated growth hormone deficiency. These studies demonstrate that peripheral blood mononuclear cells from a subset of patients with common variable hypogammaglobulinemia retain the potential to produce specific antibody in response to antigenic stimulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863541      PMCID: PMC370376          DOI: 10.1172/jci110926

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Functional differentiation of B lymphocytes in agammaglobulinemia. III. Characterization of spontaneous suppressor cell activity.

Authors:  H M Dosch; E W Gelfand
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

2.  Heterogeneity of "acquired" or common variable agammaglobulinemia.

Authors:  R S Geha; E Schneeberger; E Merler; F S Rosen
Journal:  N Engl J Med       Date:  1974-07-04       Impact factor: 91.245

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases.

Authors:  J L Preud'Homme; C Griscelli; M Seligmann
Journal:  Clin Immunol Immunopathol       Date:  1973-01

5.  Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation.

Authors:  M D Cooper; A R Lawton; D E Bockman
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

6.  The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.

Authors:  T A Waldmann; S Broder; R Krakauer; R P MacDermott; M Durm; C Goldman; B Meade
Journal:  Fed Proc       Date:  1976-07

7.  Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.

Authors:  H G Herrod; R H Buckley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; J Kasel; R M Chanock
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

9.  Functional differentiation of B lymphocytes in congenital agammaglobulinemia. I. Generation of hemolytic plaque-forming cells.

Authors:  H M Dosch; M E Percy; E W Gelfand
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

10.  Differentiation capacity of cultured B lymphocytes from immunodeficient patients.

Authors:  L Y Wu; A R Lawton; M D Cooper
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more
  3 in total

1.  Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Authors:  R Yarchoan; H G Guo; M Reitz; A Maluish; H Mitsuya; S Broder
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

2.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Authors:  R Yarchoan; R R Redfield; S Broder
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Impaired antipneumococcal antibody production in patients without spleens.

Authors:  F Di Padova; M Dürig; F Harder; C Di Padova; C Zanussi
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.